Table 3.

Prevalence of HGV infection from different groups in Southern China

Group	cases	HGV RNA Positive cases(%)
Bone marrow transplantation	108	45(41.67)
Haemodialysis	92	13(14.13)
Intravenous drug users	84	15(17.86)
Hepatocellular carcinoma	161	22(13.66)
Hepatitis B	263	19(7.22)
Hepatitis C	55	7(12.73)
Hepatitis B + Hepatitis A	16	1(6.25)
Hepatitis B + Hepatitis C	6	1(16.67)
Hepatitis B + Hepatitis E	26	3(11.54)
Hepatitis E	29	2(6.90)
Non A-E hepatitis	83	21(25.30)
Blood donors	506	13(2.57)
General population	562	5(0.89)
Total	1991